Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 905680, 9 pages
http://dx.doi.org/10.1155/2014/905680
Research Article

EMMPRIN Expression in Oral Squamous Cell Carcinomas: Correlation with Tumor Proliferation and Patient Survival

1Molecular Oncology Group, Institute of Research and Advanced Training in Health Sciences and Technologies (IINFACTS), Higher Institute of Health Sciences, CESPU, 4585-116 Paredes, Portugal
2Medicine and Oral Surgery Department, Higher Institute of Health Sciences, 4585-116 Paredes, Portugal
3Pathology Department, Higher School of Health of Vale do Sousa, 4585-116 Paredes, Portugal
4Differentiation and Cancer Group, Institute of Molecular Pathology and Immunology of the University of Porto, (IPATIMUP), 4200-465 Porto, Portugal
5Stomatology Department, Santo António Hospital, Oporto Hospitalar Centre, 4099-001 Porto, Portugal
6Molecular Pathology and Immunology Department, Institute of Biomedical Sciences Abel Salazar (ICBAS), Porto University, 4050-313 Porto, Portugal
7Centro de Química Medicinal da Universidade do Porto (CEQUIMED-UP), Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal
8Centro Interdisciplinar de Investigação Marinha e Ambiental (CIIMAR/CIMAR), Universidade do Porto, Rua dos Bragas 289, 4050-123 Porto, Portugal

Received 14 February 2014; Revised 28 April 2014; Accepted 5 May 2014; Published 21 May 2014

Academic Editor: Mouldy Sioud

Copyright © 2014 Luís Silva Monteiro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Warnakulasuriya, “Global epidemiology of oral and oropharyngeal cancer,” Oral Oncology, vol. 45, no. 4-5, pp. 309–316, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. W. C. Hahn and R. A. Weinberg, “Rules for making human tumor cells,” The New England Journal of Medicine, vol. 347, no. 20, pp. 1593–1603, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. K. T. Iacono, A. L. Brown, M. I. Greene, and S. J. Saouaf, “CD147 immunoglobulin superfamily receptor function and role in pathology,” Experimental and Molecular Pathology, vol. 83, no. 3, pp. 283–295, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Riethdorf, N. Reimers, V. Assmann et al., “High incidence of EMMPRIN expression in human tumors,” International Journal of Cancer, vol. 119, no. 8, pp. 1800–1810, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Zucker, M. Hymowitz, E. E. Rollo et al., “Tumorigenic potential of extracellular matrix metalloproteinase inducer,” The American Journal of Pathology, vol. 158, no. 6, pp. 1921–1928, 2001. View at Google Scholar · View at Scopus
  7. Y. Tang, M. T. Nakada, P. Kesavan et al., “Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases,” Cancer Research, vol. 65, no. 8, pp. 3193–3199, 2005. View at Google Scholar · View at Scopus
  8. Z. Huang, L. Wang, Y. Wang et al., “Overexpression of CD147 contributes to the chemoresistance of head and neck squamous cell carcinoma cells,” Journal of Oral Pathology & Medicine, vol. 42, no. 7, pp. 541–546, 2013. View at Google Scholar
  9. S. Suzuki and K. Ishikawa, “Combined inhibition of EMMPRIN and epidermal growth factor receptor prevents the growth and migration of head and neck squamous cell carcinoma cells,” International Journal of Oncology, vol. 44, no. 3, pp. 912–917, 2014. View at Publisher · View at Google Scholar
  10. J. Afonso, A. Longatto-Filho, F. Baltazar et al., “CD147 overexpression allows an accurate discrimination of bladder cancer patients' prognosis,” European Journal of Surgical Oncology, vol. 37, no. 9, pp. 811–817, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. Z. Huang, H. Huang, H. Li, W. Chen, and C. Pan, “EMMPRIN expression in tongue squamous cell carcinoma,” Journal of Oral Pathology and Medicine, vol. 38, no. 6, pp. 518–523, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Piao, S. Zhao, F. Guo et al., “Increased expression of CD147 and MMP-9 is correlated with poor prognosis of salivary duct carcinoma,” Journal of Cancer Research and Clinical Oncology, vol. 138, no. 4, pp. 627–635, 2012. View at Publisher · View at Google Scholar
  13. A. Stenzinger, D. Wittschieber, M. von Winterfeld et al., “High extracellular matrix metalloproteinase inducer/CD147 expression is strongly and independently associated with poor prognosis in colorectal cancer,” Human Pathology, vol. 43, no. 9, pp. 1471–1481, 2012. View at Publisher · View at Google Scholar
  14. X. Yang, J. Dai, T. Li et al., “Expression of EMMPRIN in adenoid cystic carcinoma of salivary glands: correlation with tumor progression and patients' prognosis,” Oral Oncology, vol. 46, no. 10, pp. 755–760, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Zhao, W. Ma, M. Zhang et al., “High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients,” Medical Oncology, vol. 30, no. 1, article 335, 2013. View at Publisher · View at Google Scholar
  16. S. Zhu, D. Chu, Y. Zhang et al., “EMMPRIN/CD147 expression is associated with disease-free survival of patients with colorectal cancer,” Medical Oncology, vol. 30, no. 1, article 369, 2013. View at Publisher · View at Google Scholar
  17. S. Zhu, Y. Li, L. Mi et al., “Clinical impact of HAb18G/CD147 expression in esophageal squamous cell carcinoma,” Digestive Diseases and Sciences, vol. 56, no. 12, pp. 3569–3576, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Yang, Y. Yuan, H. Zhang et al., “Prognostic significance of CD147 in patients with glioblastoma,” Journal of Neuro-Oncology, vol. 115, no. 1, pp. 19–26, 2013. View at Publisher · View at Google Scholar
  19. X. Y. Xu, N. Lin, Y. M. Li et al., “Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer,” Pathology—Research and Practice, vol. 209, no. 6, pp. 345–352, 2013. View at Publisher · View at Google Scholar
  20. M. Brandwein-Gensler and R. V. Smith, “Prognostic indicators in head and neck oncology including the new 7th edition of the AJCC staging system,” Head and Neck Pathology, vol. 4, no. 1, pp. 53–61, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Barnes, J. W. Eveson, P. Reichart, and D. Sidransky, Pathology and Genetics of Head and Neck Tumours, World Health Organization Classification of Tumours, IARC Press, Lyon, France, 2005.
  22. L. S. Monteiro, M. Diniz-Freitas, T. Garcia-Caballero, J. Forteza, and M. Fraga, “EGFR and Ki-67 expression in oral squamous cell carcinoma using tissue microarray technology,” Journal of Oral Pathology & Medicine, vol. 39, no. 7, pp. 571–578, 2010. View at Google Scholar · View at Scopus
  23. J. Carlos de Vicente, A. Herrero-Zapatero, M. F. Fresno, and J. S. López-Arranz, “Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance,” Oral Oncology, vol. 38, no. 3, pp. 301–308, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Li, J. Xu, and L. Chen, “HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection,” Histopathology, vol. 54, no. 6, pp. 677–687, 2009. View at Publisher · View at Google Scholar
  25. X. Gou, H. Chen, F. Jin et al., “Expressions of CD147, MMP-2 and MMP-9 in laryngeal carcinoma and its correlation with poor prognosis,” Pathology & Oncology Research, vol. 20, no. 2, pp. 475–481, 2014. View at Google Scholar
  26. N. Vigneswaran, S. Beckers, S. Waigel et al., “Increased EMMPRIN (CD 147) expression during oral carcinogenesis,” Experimental and Molecular Pathology, vol. 80, no. 2, pp. 147–159, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. H. C. Zheng, H. Takahashi, Y. Murai et al., “Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis,” The British Journal of Cancer, vol. 95, no. 10, pp. 1371–1378, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Sweeny, Z. Liu, B. D. Bush et al., “CD147 and AGR2 expression promote cellular proliferation and metastasis of head and neck squamous cell carcinoma,” Experimental Cell Research, vol. 318, no. 14, pp. 1788–1798, 2012. View at Publisher · View at Google Scholar
  29. X. Yang, P. Zhang, Q. Ma et al., “EMMPRIN silencing inhibits proliferation and perineural invasion of human salivary adenoid cystic carcinoma cells in vitro and in vivo,” Cancer Biology & Therapy, vol. 13, no. 2, pp. 85–91, 2012. View at Publisher · View at Google Scholar
  30. C. Zhu, Y. Pan, B. He et al., “Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to cisplatin in laryngeal carcinoma Hep2 cells,” Oncology Reports, vol. 25, no. 2, pp. 425–432, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Li, Q. Zhai, U. Bharadwaj et al., “Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147,” Cancer, vol. 106, no. 10, pp. 2284–2294, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Huang, Z. Sun, Y. Sun et al., “Association of increased ligand cyclophilin A and receptor CD147 with hypoxia, angiogenesis, metastasis and prognosis of tongue squamous cell carcinoma,” Histopathology, vol. 60, no. 5, pp. 793–803, 2012. View at Publisher · View at Google Scholar
  33. C. Pinheiro, A. Longatto-Filho, K. Simões et al., “The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer,” European Journal of Cancer, vol. 45, no. 13, pp. 2418–2424, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Davidson, I. Goldberg, A. Berner, G. B. Kristensen, and R. Reich, “EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma,” Clinical and Experimental Metastasis, vol. 20, no. 2, pp. 161–169, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. J. Xue, Q. Lu, and Z. X. Sun, “CD147 overexpression is a prognostic factor and a potential therapeutic target in bladder cancer,” Medical Oncology, vol. 28, no. 4, pp. 1363–1372, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. X. C. Bi, J. M. Liu, H. C. He et al., “Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomas,” Clinical and Translational Oncology, vol. 14, no. 3, pp. 190–196, 2012. View at Publisher · View at Google Scholar
  37. G. Rabinowits and R. I. Haddad, “Overcoming resistance to EGFR inhibitor in head and neck cancer: a review of the literature,” Oral Oncology, vol. 48, no. 11, pp. 1085–1089, 2012. View at Publisher · View at Google Scholar
  38. L. S. Monteiro, M. L. Delgado, S. Ricardo et al., “Phosphorylated mammalian target of rapamycin is associated with an adverse outcome in oral squamous cell carcinoma,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, vol. 115, no. 5, pp. 638–645, 2013. View at Publisher · View at Google Scholar
  39. N. R. Dean, J. R. Newman, E. E. Helman et al., “Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer,” Clinical Cancer Research, vol. 15, no. 12, pp. 4058–4065, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. L. Sweeny, Y. E. Hartman, K. R. Zinn et al., “A novel extracellular drug conjugate significantly inhibits head and neck squamous cell carcinoma,” Oral Oncology, vol. 49, no. 10, pp. 991–997, 2013. View at Publisher · View at Google Scholar